Skip to main content
Caplight Logo









Viage Therapeutics

Viage Therapeutics

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://www.viagetx.com/

Last Round

Seed

Jan 6, 2022

Total Funding Raised

$10M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Viage Therapeutics is a biotechnology company that develops drugs to treat psychiatric and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gut-brain axisneurotherapeuticscognitive impairmentoral therapeuticsgut-restricted therapyclinical stage biotechneuro-biotechvagus nerve modulationAlzheimer's diseaseParkinson's diseasegut-brain connectiondrug developmentdrug licensingCNS disordersAVPR1A receptorpsychiatric disorders

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Viage Therapeutics Comparables

Compare Viage Therapeutics with similar companies based on industry and business-model similarity.

Viage Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stellate Therapeutics Inc.
84%
Axial Therapeutics
77%
Holobiome
73%

Viage Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 6, 2022

Viage Therapeutics Investors

Notable investors and investment history

Viage Therapeutics investors
InvestorRounds
Remiges VenturesSeed
ANRI株式会社Seed
Miyako CapitalSeed
Kyoto University Innovation CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Web traffic grew 116% MoM (from 1.3K to 2.9K monthly visitors)

  • Jul 24, 2026

    Monthly visitors increased 117% MoM.

Viage Therapeutics Filings

Explore SEC and related filing metadata, where available.

Viage Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Viage Therapeutics's valuation, stock price, and market status.

Is Viage Therapeutics a public or private company?

Viage Therapeutics is a private company.

What is the current stock price of Viage Therapeutics?

Viage Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Viage Therapeutics worth (valuation)?

Valuation information for Viage Therapeutics is not publicly available.

Can I buy Viage Therapeutics stock?

Viage Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Viage Therapeutics's last funding round?

Funding round information for Viage Therapeutics is not publicly available.

Who are the main investors in Viage Therapeutics?

Investor information for Viage Therapeutics is not publicly disclosed.

Will Viage Therapeutics IPO soon?

No public IPO plans have been announced for Viage Therapeutics.

How can I track Viage Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Viage Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRedwood City, California
Employee Range1
Year Founded2018
Last FundingJan 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?